Decoding the striatum of drug-naive patients with obsessive-compulsive disorder: a transcriptome and longitudinal functional magnetic resonance imaging study.
{"title":"Decoding the striatum of drug-naive patients with obsessive-compulsive disorder: a transcriptome and longitudinal functional magnetic resonance imaging study.","authors":"Yiding Han, Haohao Yan, Xiaoxiao Shan, Huabing Li, Feng Liu, Ping Li, Dongsheng Lv, Jingping Zhao, Wenbin Guo","doi":"10.1038/s41398-025-03475-4","DOIUrl":null,"url":null,"abstract":"<p><p>The striatum's role in obsessive-compulsive disorder (OCD) pathology is recognized. However, the specific contributions of individual striatal subregions (SSs) to OCD pathology are underexplored. We recruited 49 drug-naive OCD patients and 53 healthy controls, conducting clinical assessments and resting-state functional magnetic resonance imaging (rs-fMRI) scans pre- and post-4-week paroxetine treatment. Inter-group comparisons were conducted to investigate baseline and treatment-related changes in the patients' striatum using several fMRI metrics, including amplitude of low-frequency fluctuation, regional homogeneity, and degree centrality (DC). Furthermore, these metrics, along with functional connectivity (FC), and effective connectivity (EC) of SSs, were analyzed. Associations between gene expression patterns and altered information flow patterns in SSs were examined, where information flow was measured using EC, followed by enrichment analysis of relevant genes. While no significant alterations were observed in the patients' striata in whole-brain statistical analyses, significant changes in DC, FC, and EC were identified in SSs pre- and post-treatment. In particular, the EC analysis unveiled an enhanced top-down control and diminished bottom-up regulation in drug-naive OCD patients. Following treatment, bottom-up EC improved, along with an improvement in clinical symptoms. Additionally, information flow alteration-related genes were enriched in various biological processes and pathways. They substantially overlapped between bidirectional information flows among SSs and the rest of brain and between information flows among homotopical SSs and the rest of brain. This study highlights the diverse contributions of each striatal subregion to OCD pathology. Paroxetine may alleviate OCD symptoms by enhancing bottom-up regulation, specifically the normalization of aberrant connectivity. Furthermore, integrating transcriptomic and rs-fMRI findings offer novel insights into the biological substrates underlying the altered EC of SSs in OCD patients.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"15 1","pages":"258"},"PeriodicalIF":6.2000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304266/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-025-03475-4","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
The striatum's role in obsessive-compulsive disorder (OCD) pathology is recognized. However, the specific contributions of individual striatal subregions (SSs) to OCD pathology are underexplored. We recruited 49 drug-naive OCD patients and 53 healthy controls, conducting clinical assessments and resting-state functional magnetic resonance imaging (rs-fMRI) scans pre- and post-4-week paroxetine treatment. Inter-group comparisons were conducted to investigate baseline and treatment-related changes in the patients' striatum using several fMRI metrics, including amplitude of low-frequency fluctuation, regional homogeneity, and degree centrality (DC). Furthermore, these metrics, along with functional connectivity (FC), and effective connectivity (EC) of SSs, were analyzed. Associations between gene expression patterns and altered information flow patterns in SSs were examined, where information flow was measured using EC, followed by enrichment analysis of relevant genes. While no significant alterations were observed in the patients' striata in whole-brain statistical analyses, significant changes in DC, FC, and EC were identified in SSs pre- and post-treatment. In particular, the EC analysis unveiled an enhanced top-down control and diminished bottom-up regulation in drug-naive OCD patients. Following treatment, bottom-up EC improved, along with an improvement in clinical symptoms. Additionally, information flow alteration-related genes were enriched in various biological processes and pathways. They substantially overlapped between bidirectional information flows among SSs and the rest of brain and between information flows among homotopical SSs and the rest of brain. This study highlights the diverse contributions of each striatal subregion to OCD pathology. Paroxetine may alleviate OCD symptoms by enhancing bottom-up regulation, specifically the normalization of aberrant connectivity. Furthermore, integrating transcriptomic and rs-fMRI findings offer novel insights into the biological substrates underlying the altered EC of SSs in OCD patients.
期刊介绍:
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.